vs
Immunovant, Inc.（IMVT）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
SWK Holdings Corp的季度营收约是Immunovant, Inc.的1.0倍（$8.7M vs $8.4M），Immunovant, Inc.同比增速更快（140.7% vs -29.7%），SWK Holdings Corp自由现金流更多（$26.8M vs $-59.8M）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
IMVT vs SWKH — 直观对比
营收规模更大
SWKH
是对方的1.0倍
$8.4M
营收增速更快
IMVT
高出170.4%
-29.7%
自由现金流更多
SWKH
多$86.6M
$-59.8M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $8.7M |
| 净利润 | $-75.3M | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | 9.9% |
| 净利率 | -899.0% | — |
| 营收同比 | 140.7% | -29.7% |
| 净利润同比 | -26.7% | -430.2% |
| 每股收益（稀释后） | $-0.50 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMVTSWKH
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $10.4M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | $8.4M | $11.4M |
净利润IMVTSWKH
| Q4 25 | — | $-19.4M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | — | $3.5M | ||
| Q2 24 | — | $3.7M | ||
| Q1 24 | $-75.3M | $468.0K |
营业利润率IMVTSWKH
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 46.1% | ||
| Q1 25 | — | 68.6% | ||
| Q4 24 | — | 44.7% | ||
| Q3 24 | — | 39.2% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | -896.2% | 9.5% |
净利率IMVTSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 80.7% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 38.4% | ||
| Q4 24 | — | 47.5% | ||
| Q3 24 | — | 33.3% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | -899.0% | 4.1% |
每股收益（稀释后）IMVTSWKH
| Q4 25 | — | $-1.59 | ||
| Q3 25 | — | $0.72 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | — | $0.37 | ||
| Q4 24 | — | $0.47 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | $-0.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $617.8M | $235.1M |
| 总资产 | $666.4M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资IMVTSWKH
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $29.8M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | — | $17.2M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | $635.4M | $5.5M |
总债务IMVTSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益IMVTSWKH
| Q4 25 | — | $235.1M | ||
| Q3 25 | — | $254.2M | ||
| Q2 25 | — | $246.5M | ||
| Q1 25 | — | $292.7M | ||
| Q4 24 | — | $288.7M | ||
| Q3 24 | — | $283.4M | ||
| Q2 24 | — | $282.8M | ||
| Q1 24 | $617.8M | $279.9M |
总资产IMVTSWKH
| Q4 25 | — | $272.4M | ||
| Q3 25 | — | $289.4M | ||
| Q2 25 | — | $285.7M | ||
| Q1 25 | — | $331.3M | ||
| Q4 24 | — | $332.2M | ||
| Q3 24 | — | $321.3M | ||
| Q2 24 | — | $321.0M | ||
| Q1 24 | $666.4M | $322.0M |
负债/权益比IMVTSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $26.8M |
| 自由现金流率自由现金流/营收 | -714.4% | 308.1% |
| 资本支出强度资本支出/营收 | 1.8% | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $43.2M |
8季度趋势，按日历期对齐
经营现金流IMVTSWKH
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $906.0K | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $23.0M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | $-59.7M | $4.4M |
自由现金流IMVTSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | — | $22.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | $-59.8M | — |
自由现金流率IMVTSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | — | 185.3% | ||
| Q3 24 | — | 60.4% | ||
| Q2 24 | — | 49.7% | ||
| Q1 24 | -714.4% | — |
资本支出强度IMVTSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | 1.8% | 0.0% |
现金转化率IMVTSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMVT
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
